A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010)
Clinical trial NCT01651936 · TERMINATED
Trial details
- NCT number
- NCT01651936
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-29
- Primary completion
- 2013-10-08
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.